Drug History: SEREVENT

DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST

Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Label and Approval History

Drug Name:	SEREVENT
FDA Application No:	(NDA) 020692
Active Ingredient(s):	SALMETEROL XINAFOATE
Company:	GLAXO GRP LTD

Label History

View the label approved on March 3, 2006 for SEREVENT, (NDA) 020692

To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.

Approval History

Action Date	Supplement Number	Approval Type	Letters, Reviews, Labels, Patient Package Insert
3/2/2006	029	Labeling Revision	Letter Label Other Important Information from FDA
2/23/2007	028	Labeling Revision	Letter Label
9/28/2004	026	Labeling Revision	Letter Label
8/11/2003	024	Labeling Revision	Letter Label
5/17/2002	020	Control Supplement
5/15/2002	018	Manufacturing Change or Addition
10/16/2001	017	Control Supplement
3/22/2002	016	New or Modified Indication	Letter Label
5/17/2001	015	Labeling Revision
6/15/2000	013	Control Supplement
4/3/2000	012	Control Supplement
6/29/2000	011	Efficacy Supplement with Clinical Data to Support
7/20/1999	010	Manufacturing Change or Addition
1/19/2001	009	Control Supplement
3/18/1998	008	Control Supplement
3/11/1998	007	Labeling Revision
12/3/1998	006	Control Supplement
3/18/1998	004	Control Supplement
3/26/1998	003	Control Supplement
9/25/1998	002	Patient Population Altered	Letter Label Review
9/25/1998	001	New or Modified Indication	Letter Label Review
9/19/1997	000	Approval	Review Medication Guide Other Important Information from FDA

There are no Therapeutic Equivalents